Alpha 2.0
Login Register
» Authors » Ayman Hijazy

Ayman Hijazy

Explore the profile of Ayman Hijazy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 3
Citations 6
Followers 0
Related Specialties
General Surgery
Urology
Top 10 Co-Authors
Asieh Golozar
Susan Evans-Axelsson
Carl Steinbeisser
James Ndow
Thomas Abbott
Bertrand De Meulder
Rossella Nicoletti
Riccardo Campi
Francesco Pellegrino
Tim Hulsen
Published In
Eur Urol
Eur Urol Open Sci
Int J Surg Protoc
Affiliations
Soon will be listed here.
Recent Articles
1.
Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI's "big data for better outcomes" program
Gandaglia G, Pellegrino F, De Meulder B, Hijazy A, Abbott T, Golozar A, et al.
Int J Surg Protoc . 2024 Jun; 28(2):64-72. PMID: 38854711
Background: Metastatic prostate cancer (PCa) constitutes ~5% of all new PCa diagnoses in Western countries. For most cases, primary consideration should be given to systemic therapies as the first-line approach...
2.
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform
Rajwa P, Borkowetz A, Abbott T, Alberti A, Bjartell A, Brash J, et al.
Eur Urol Open Sci . 2024 Apr; 63:81-88. PMID: 38572301
Combination therapies in metastatic hormone-sensitive prostate cancer (mHSPC), which include the addition of an androgen receptor signaling inhibitor and/or docetaxel to androgen deprivation therapy, have been a game changer in...
3.
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data
Gandaglia G, Pellegrino F, Golozar A, De Meulder B, Abbott T, Achtman A, et al.
Eur Urol . 2023 Jul; 85(5):457-465. PMID: 37414703
Background: Conservative management is an option for prostate cancer (PCa) patients either with the objective of delaying or even avoiding curative therapy, or to wait until palliative treatment is needed....